UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10

UT 西南 NCI 国家临床试验网络主要学术网站 - U10

• 批准号: 9248972
• 负责人: David Eric Gerber
• 金额: $ 70万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-09 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9248972
• 关键词: Academic Medical Centers; Adult; African American; American Cancer Society; American College of Radiology Imaging Network; American College of Surgeons Oncology Group; American Society of Clinical Oncology; Area; Basic Science; Breast; Cancer Center; Chest; Clinic; Clinical; Clinical Research; Clinical Trials; Collaborations; Country; Department chair; Discipline; Disease; Eastern Cooperative Oncology Group; Enrollment; Ethics; Ethnic Origin; Faculty; Funding; Grant; Gynecologic Oncology Group; Head and neck structure; Hematology; Heme; Hispanics; Image; Institution; Lead; Leadership; Lung; Magnetic Resonance Imaging; Malignant neoplasm of lung; Medical center; Mentors; NCI-Designated Cancer Center; National Clinical Trials Network; National Surgical Adjuvant Breast and Bowel Project; Oncology Group; Patients; Physician Executives; Population; Positioning Attribute; Positron-Emission Tomography; Principal Investigator; Publications; Radiation Oncology; Radiation Therapy Oncology Group; Recording of previous events; Recruitment Activity; Research; Research Personnel; Role; Services; Site; Southwest Oncology Group; Texas; Therapeutic; Translating; Translational Research; Universities; cancer diagnosis; career development; drug discovery; ethnic diversity; ethnic minority population; innovation; medical schools; member; metropolitan; multidisciplinary; neuro-oncology; oncology; patient oriented; patient population; programs; public health relevance; quantitative imaging; racial and ethnic; racial minority; translational scientist

DESCRIPTION (provided by applicant): The University of Texas Southwestern Medical Center (UTSW) has a history of leadership, translational research, and accrual to cooperative group trials. The PI of this grant is Dr. Joan Schiller, chief of the Division of Heme/Oncology and Deputy Director of the Simmons Cancer Center (SCC), former Chair of ECOG's Thoracic Committee and currently PI of UTSW's main institution ECOG grant. Co-investigators include Dr. Hak Choy, Chair of UTSW's Department of Radiation Oncology, Vice Chair for Disease Sites in RTOG, and former Chair of RTOG's Thoracic Committee; Dr. David Miller, member of the GOG Board of Directors and Chair of the Uterine Corpus Committee; Dr. Marilyn Leitch, member of the Executive Committee of ACOSOG, and Dr. Phil Evans, immediate past president of the American Cancer Society, who was one of the founding members of the ACRIN Breast committee, and served as the principal investigator at UTSW for ACRIN sponsored trials. In 2012, UTSW enrolled 105 patients on adult co-operative group trials. Since 2006, UTSW faculty have investigated or co-investigated 96 co-operative group publications and 85 abstracts, and have chaired, co-chaired, or served as cooperative committee chair on 34 cooperative group trials. UTSW is also a site for the NCI Centers Quantitative imaging Excellence. UTSW is the only academic medical center and medical school in the Dallas/Ft. Worth (DFW) Metroplex, the fourth largest metropolitan area in the country, and is the only NCI designated Cancer Center in north Texas. UTSW also has a strong clinical and transitional research program and drug discovery program; a SPORE in lung cancer; an Advanced Imaging Research Center; and has access to a diverse ethnic and racial population. In the DFW Metroplex, roughly 10.3% of the populations with a cancer diagnosis are Hispanic, and 14.1% are African American; in 2012, 29.6% of SCC patients going on co-operative group clinical studies were of Hispanic ethnicity, and 13.6% were of African American ancestry. The specific aims of the UTSW UIO are to contribute to and promote: (1) The NCTN by enrolling patients with diverse ethnic and racial background on therapeutic and non-therapeutic trials; (2) The scientific direction of the NCTN by bringing the basic, translational, and imaging research conducted at UTSW into hypothesis driven clinical trials. (3) Multidisciplinary efforts and collaboration across multiple disciplinesand multiple cooperative groups; (4) Service in leadership roles by chairing and co-chairing clinical trials and committees, and by participating in NCI activities and initiatives; and (5) The career development of junior faculty.

描述（由申请人提供）：德克萨斯大学西南医学中心（UTSW）具有领导，转化研究和合作小组试验的历史。这笔拨款的首席研究员是琼·席勒医生，他是血红素/肿瘤科的主任